Cardio Diagnostics Holdings Inc
Ticker(s):
CDIO and CDIOW
Country:
Sector & Industry:
Business Overview
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Contact & Other Information
Number of Employees:
7
Website:
311 West Superior Street
Suite 444
Chicago
,
IL
,
60654
United States
302 281 2147
02/21/2025 | 8-K | 0001079973-25-000308 |
Cardio Diagnostics Holdings Inc. will begin using an investor presentation to present to existing and prospective investors, highlighting their technology and recent milestones.